Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
The Mainstreaming Addiction Treatment Act (H.R. 2482) will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X Waiver" DEA certificate and the
SHM sent a support letter to Reps. Blumenauer and Mullin for their legislation, the Overdose Prevention and Patient Safety Act.
SHM urges Congress to act now to restore funding for CHIP and ensure millions of children nationwide have access to health care. We stand ready to help move this important priority forward.
SHM has submitted comments on the 2023 PFS Proposed Rule. SHM commented on various proposals including, but not limited to, telehealth, split (or shared) billing, code valuations, and the Quality
SHM has submitted comments on a wide-ranging RFI, commenting on issues like health equity, prior authorization, telehealth expansion, and more.
Prior authorization requirements under Medicare Advantage (MA) plans often result in unnecessary delays or denials in medically necessary care. SHM has submitted comments to CMS to encourage the
SHM sent a letter to CMS on the new split (or shared) billing policy. This policy will be extremely disruptive to team-based care and is not reflective of the realities of hospitalist practice.
SHM submitted comments to the FDA regarding pulse oximetry device's inaccurate readings on patients with darker skin pigmentation.
SHM submitted comments on the Prior Authorization for Hospital Transfers RFI. We outlined the importance of increasing transparency and efficiency of the prior authorization process under
In light of the Supreme Court's decision on Dobbs vs. Jackson Women's Health System, SHM, alongside 74 other medical and specialty societies, oppose legislative interference into the